Overview
Atrial Fibrillation
Cancer Associated Thrombosis
The Promise of Factor XI
Abelacimab: A Novel Anticoagulant
Clinical Development Program
Our Mission
Our Team
Milestones & Achievements
Patient Advocacy
Healthcare Professionals
Forbes
https://www.forbes.com/sites/alexknapp/2023/11/15/innovationrx-a-new-blood-thinner-on-the-horizon/?sh=2455e1c12295
